✦ LIBER ✦

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age

✍ Scribed by Heyward, William L.; Kyle, Michael; Blumenau, Joseph; Davis, Matthew; Reisinger, Keith; Kabongo, Martin L.; Bennett, Sean; Janssen, Robert S.; Namini, Hamid; Martin, J. Tyler

Book ID: 123092976
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 517 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2013.05.068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of an investig

Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease

✍ Janssen, Robert S.; Mangoo-Karim, Roberto; Pergola, Pablo E.; Girndt, Matthias; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 961 KB

Comparison of safety and immunogenicity

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age

✍ Scott A. Halperin; Brian Ward; Curtis Cooper; Gerald Predy; Francisco Diaz-Mitom 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 344 KB